When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KRTX - Intra-Cellular drug approval augurs well for CNS stocks Stifel says
Karuna Therapeutics Inc.
The FDA's approval of Intra-Cellular Therapies' (ITCI+191.6%) schizophrenia drug bodes well for other companies with therapies for the central nervous system, writes Stifel analyst Paul Matteis.
More news on: Intra-Cellular Therapies, Inc., Sage Therapeutics, Inc., ACADIA Pharmaceuticals Inc., Healthcare stocks news, Stocks on the move,